首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   4984篇
  免费   59篇
  国内免费   9篇
电工技术   51篇
综合类   11篇
化学工业   556篇
金属工艺   45篇
机械仪表   64篇
建筑科学   143篇
矿业工程   6篇
能源动力   60篇
轻工业   239篇
水利工程   29篇
石油天然气   6篇
武器工业   1篇
无线电   366篇
一般工业技术   472篇
冶金工业   2565篇
原子能技术   35篇
自动化技术   403篇
  2021年   31篇
  2019年   22篇
  2018年   39篇
  2017年   37篇
  2016年   32篇
  2015年   27篇
  2014年   59篇
  2013年   169篇
  2012年   74篇
  2011年   107篇
  2010年   90篇
  2009年   90篇
  2008年   104篇
  2007年   103篇
  2006年   82篇
  2005年   129篇
  2004年   79篇
  2003年   84篇
  2002年   74篇
  2001年   77篇
  2000年   65篇
  1999年   118篇
  1998年   713篇
  1997年   427篇
  1996年   301篇
  1995年   217篇
  1994年   180篇
  1993年   174篇
  1992年   70篇
  1991年   62篇
  1990年   75篇
  1989年   76篇
  1988年   76篇
  1987年   77篇
  1986年   72篇
  1985年   79篇
  1984年   43篇
  1983年   39篇
  1982年   37篇
  1981年   50篇
  1980年   57篇
  1979年   37篇
  1978年   28篇
  1977年   85篇
  1976年   156篇
  1975年   31篇
  1974年   25篇
  1973年   18篇
  1972年   19篇
  1971年   18篇
排序方式: 共有5052条查询结果,搜索用时 15 毫秒
21.
22.
Separate injections of Haemophilus influenzae type b capsular polysaccharide-tetanus conjugate (PRP-T) vaccine and diphtheria-tetanus-pertussis (DTP) reconstitution of freeze-dried PRP-T vaccine with liquid DTP vaccine have been shown to be safe and immunogenic in infants. The present study was conducted to test the safety and immunogenicity of the liquid combination vaccine administered to young infants in the dual-chamber syringe. The study was a monocenter, open clinical trial of 3 month-old infants receiving PRP-T and DTP vaccines in the dual-chamber syringe reconstituted prior to injection. Healthy infants were immunized according to a 3, 4 and 5 months-of-age schedule. The vaccine was administered in a dual-chamber syringe, ready to use with two chambers. The proximal chamber contained freeze-dried PRP-T and the distal chamber contained liquid combination-vaccine DTP. The freeze-dried PRP-T vaccine was reconstituted with the liquid DTP vaccine in the same unidose dual-chamber syringe (0.5 mL) and was injected intramuscularly into the deltoid region. Blood sampling was performed prior to vaccination at 3 months of age and after the third vaccination at 6 months. The primary end-point was the serological response to PRP-T vaccine as expressed by the percentage of infants with an antibody titer greater than or equal to 1 microgram/mL. The reactogenicity was expressed as the percentage of reported local and systemic reactions. A total of 108 infants were included in the study and received the dual-chamber syringe vaccine. After the third injection, all the infants had a PRP antibody titer greater than or equal to 0.15 microgram/mL and 94.4% of infants had a PRP antibody titer greater than or equal to 1 microgram/mL; the pertussis agglutinin titers were over the threshold 40 and 80 in all infants and 98.1% were over the threshold 320. After the third injection, all the infants had diphtheria antibody titers greater than 0.1 IU/mL and 83.3% had titers greater than 1 IU/mL; all the infants had tetanus antibody titers greater than 0.1 IU/mL and 97.2% had results over 1 IU/mL. Thirty-seven infants (34.6%) had local reactions and 64.5% had systemic reactions. The dual-chamber syringe may reduce the cost of vaccine delivery, as well as the workload, and increase the vaccine acceptability and coverage rate of vaccines.  相似文献   
23.
OBJECTIVE: To evaluate aspects of the natural history of AA amyloidosis complicating juvenile rheumatoid arthritis (JRA), and its response to therapy with chlorambucil. METHODS: Scintigraphy and 7-day turnover studies were performed in JRA patients with histologically proven (n = 35) or clinically suspected (n = 30) AA amyloidosis, following intravenous injection of 123I and 125I-labeled serum amyloid P component (SAP). Prospective monitoring studies were performed over 2-3 years in 20 patients with amyloidosis. All but 2 amyloidosis patients were treated with chlorambucil. RESULTS: Positive scanning results were obtained in all patients in whom imaging was performed within 12 years of positive biopsy findings of amyloid and in 5 patients with clinically suspected amyloidosis. Negative scanning results with normal SAP metabolism, indicating regression of amyloid, were obtained in 4 patients whose amyloidosis had been in full clinical remission for more than 12 years. Prospective monitoring studies in patients whose JRA-associated inflammatory activity was in remission demonstrated regression of amyloid in 8 patients and no substantial changes in 8 others; however, in 4 further patients with active inflammation, there was accumulation of amyloid. There was a very poor correlation between the amount of amyloid present at a particular site and the resultant organ dysfunction. CONCLUSION: Radiolabeled SAP scintigraphy and turnover studies are useful complementary tools in the diagnosis, screening, and quantitative monitoring of type AA amyloidosis in JRA. The amyloid deposits may progress and/or regress at different rates in different anatomic sites over short periods.  相似文献   
24.
D. H. Hall 《Scientometrics》1992,24(2):237-280
This paper is the third in a series on the flows of influence at the interface between geoscience research and the exploration for and mining of nuclear fuels. It deals with the application of signal processing methods to research and industry indicators, with emphasis on time and frequency domain correlations and lags, and on growth modelling of the indicators using the special and general logistic models. The findings include the following: there was a strong interchange across the science-industry interface; quantitative methods can establish the degree of correlation and the time periods in which these correlations mainly reside; also the timing of decisions to initiate exploration and research can be specified in this case. A strategy of applying quantitative methods, history of science, and periodic analyses of the state of the industry to studies of science policy is suggested by this research.  相似文献   
25.
The performance of Nd3+-doped fibre amplifiers is limited by strong excited-state absorption (ESA) of the signal, and, even for fluorozirconate glasses, ESA prevents the important region below 1320 nm from being used. To quantify this limitation and explore alternative host materials, ESA and stimulated-emission cross sections have been measured for a representative group of glass compositions. These parameters have been used in an accurate fiber-amplifier model to provide the first quantitative comparisons of performance for Nd3+ -doped glasses in the 1300-nm band as a function of host  相似文献   
26.
To establish the relationships among T and B cell responses, active infection, and clinical manifestations in lymphatic filariasis, filarial-specific lymphocyte proliferation, IgG antibody isotypes, and IgE levels were determined in an exposed population: 31 asymptomatic amicrofilaremics, 43 microfilaremics, 12 symptomatic amicrofilaremics, and 52 elephantiasis patients. Lymphocyte proliferation was higher in elephantiasis patients and asymptomatic amicrofilaremics than in microfilaremics (P < .004). A proportion of asymptomatic amicrofilaremics (32%), elephantiasis patients (37%), and symptomatic amicrofilaremics (58%) showed antigen-specific lymphocyte unresponsiveness, and lymphocyte proliferation to filarial antigens correlated negatively with specific IgG4 levels (rho = -0.315, P < .001). As elevated specific IgG4 is an indicator of active infection, it is argued that active infection may result in lymphocyte hyporesponsiveness irrespective of clinical category. Of those with elevated specific IgE levels and high T cell proliferative responses, 70% had elephantiasis, suggesting these factors have a role in pathology. However, the existence of a proportion of elephantiasis patients with low anti-filarial IgE and T cell unresponsiveness to filarial antigens suggests that elephantiasis can be caused by distinct processes.  相似文献   
27.
28.
  相似文献   
29.
Sleep deprivation and fragmentation occurring in the hospital setting may have a negative impact on the respiratory system by decreasing respiratory muscle function and ventilatory response to CO2. Sleep deprivation in a patient with respiratory failure may, therefore, impair recovery and weaning from mechanical ventilation. We postulate that light, sound, and interruption levels in a weaning unit are major factors resulting in sleep disorders and possibly circadian rhythm disruption. As an initial test of this hypothesis, we sampled interruption levels and continuously monitored light and sound levels for a minimum of seven consecutive days in a medical ICU, a multiple bed respiratory care unit (RCU) room, a single-bed RCU room, and a private room. Light levels in all areas maintained a day-night rhythm, with peak levels dependent on window orientation and shading. Peak sound levels were extremely high in all areas representing values significantly higher than those recommended by the Environmental Protection Agency as acceptable for a hospital environment. The number of sound peaks greater than 80 decibels, which may result in sleep arousals, was especially high in the intensive and respiratory care areas, but did show a day-night rhythm in all settings. Patient interruptions tended to be erratic, leaving little time for condensed sleep. We conclude that the potential for environmentally induced sleep disruption is high in all areas, but especially high in the intensive and respiratory care areas where the negative consequences may be the most severe.  相似文献   
30.
Melvin Webber's seminal papers of 1963/64, which posited the arrival of a Nonplace Urban Realm and called upon planners to abandon their obsession with space, have proved highly prescient: metropolitan areas have deconcentrated and spread as he suggested, and the arrival of the informational age further reinforces these trends by creating a spaceless economy. But urban agglomeration economies do continue to operate, and traditional urban nodes will remain important in the new space‐economy.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号